Table 2.
Clinical, laboratory and radiological data among enrolled patients.
| COVID-19 only (n = 400) | CAM (n = 33) | P value | |
|---|---|---|---|
| Heart rate (b/m) | 86.91 ± 8.25 | 85.67 ± 8.82 | 0.41 |
| Temperature (ºC) | 38.29 ± 0.68 | 38.27 ± 0.69 | 0.95 |
| Respiratory rate (c/m) | 28.75 ± 1.67 | 29.06 ± 2.26 | 0.32 |
| Baseline hypoxemia | 328 (82%) | 28 (84.8%) | 0.44 |
| RBS (mg/dl) | 140 (90–298) | 210 (121–240) | < 0.001 |
| Leucocytes (103/µl) | 13 (1–34) | 10 (6–16) | < 0.001 |
| Lymphocytes (103/µl) | 1.30 (0.20–4) | 1.2 (0.30–3) | 0.97 |
| RDW (%) | 14.83 ± 2.81 | 15.73 ± 3.33 | 0.08 |
| Hemoglobin (mg/dl) | 13.37 ± 1.39 | 12.11 ± 1.54 | < 0.001 |
| Platelets (103/µl) | 205.87 ± 60.56 | 221.39 ± 76.26 | 0.16 |
| Raised ESR | 48 (12%) | 18 (54.5%) | < 0.001 |
| CRP (mg/dl) | 32 (0.50–119) | 24 (4–180) | 0.27 |
| d-dimer (ng/dl) | 0.60 (0.03–76) | 0.50 (0.10–95) | 0.60 |
| SOFA score | 5 (2–17) | 5 (2–18) | 0.39 |
| Chest radiologya | |||
| Consolidation | 116 (29%) | 0 | < 0.001 |
| GGO | 160 (40%) | 33 (100%) | |
| GGO and consolidation | 124 (31%) | 0 | |
| Severity of COVID-19 | |||
| Moderate | 200 (50%) | 7 (21.2%) | < 0.001 |
| Severe | 160 (40%) | 16 (48.5%) | |
| Life threatening | 40 (10%) | 10 (30.3%) | |
Data expressed as frequency (percentage), mean (SD), median (range) as appropriate. P value was significant if < 0.05.
Nominal data was compared by Chi-square test while all continuous data was compared by Student t test with exception of RBS, leucocytes, lymphocytes, CRP, D-dimer and SOFA were compared Mann Whitney test.
RBS: random blood sugar; RDW: red cell distribution width; ESR: erythrocyte sedimentation rate; CRP: C-reactive protein; GGO: ground glass opacity; SOFA: sequential organ failure assessment; COVID-19: coronavirus disease 2019. RBS: random blood sugar.
Significant values are given in bold.
aIncluded chest computed tomography and plain radiograph.